TraceLink Lands $51,500,000 Series C Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    200 Quannapowitt Parkway Wakefield, MA 01880 USA
  • Company Description
    TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    This investment will enable TraceLink to improve its position in the global pharmaceutical track and trace industry, providing manufacturers, distributors and dispensers with a cost-effective solution to secure the drug supply chain and protect patients from counterfeit medicines, a problem that causes hundreds of thousands of deaths and leads to an estimated $75 billion in lost industry revenue each year.
  • M&A Terms
  • Venture Investor
    Goldman Sachs
  • Venture Investor
    FirstMark Capital
  • Venture Investor
    Volition Capital
  • Venture Investor
    F-Prime Capital

Trending on Xconomy